SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
Press Releases
SK bioscience  
October 23, 2024

SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia

This approval paves the way for exports to the world's fourth most populous country.SK bioscience aims to continue to grow as a global vaccine brand beyond Korea by leveraging the

logo salamanca press

Salamanca Press

Local & Social